angioplasty

Carotid Endarterectomy vs. Carotid Angioplasty in Symptomatic and Asymptomatic Patients: 30-Day Outcomes

Extracranial carotid artery disease represents 15 to 20% of all strokes. Carotid revascularization plays a role in primary and secondary prevention of cerebrovascular events. Outcomes of two common revascularization strategies, Carotid endarterectomy (CAE) and carotid artery stenting (CAS), have been studied and compared. In recent years, complications associated to CAS have dropped thanks to technical<a href="https://solaci.org/en/2024/04/24/carotid-endarterectomy-vs-carotid-angioplasty-in-symptomatic-and-asymptomatic-patients-30-day-outcomes/" title="Read more" >...</a>

Nuevas estrategias en el territorio femoropoplíteo

Drug-Coated Balloon Angioplasty in Femoropopliteal CTOs: Intraluminal or Subintimal?

Patients with peripheral vascular disease often experience femoropopliteal compromise. It is estimated that approximately 50% of lesions in this area are chronic total occlusions (CTO). Even though success rate has improved for peripheral CTO treatments, long term clinical and technical outcomes have not been fully determined yet.&nbsp; Prior research has looked into stenting outcomes in<a href="https://solaci.org/en/2024/04/19/drug-coated-balloon-angioplasty-in-femoropopliteal-ctos-intraluminal-or-subintimal/" title="Read more" >...</a>

Impella

Impella in High Risk Coronary Angioplasty before TAVR

The population is aging, which is closely related with the presence of aortic stenosis. This condition, as we know, is associated with coronary artery disease (CAD) approximately in 50% of cases. In high risk surgical patients, this calls for procedures such as percutaneous coronary intervention (PCI) and transcatheter aortic valve replacement (TAVR).&nbsp;&nbsp; PCI with ventricular<a href="https://solaci.org/en/2023/11/08/impella-in-high-risk-coronary-angioplasty-before-tavr/" title="Read more" >...</a>

FFR Post Angioplastia

Complex Coronary Angioplasty in Elderly Patients: Problem or Solution?

Cardiovascular disease is the leading cause of death in elderly adults (individuals aged 75&nbsp;years or older). In turn, coronary heart disease is one of the main causes of morbidity in this population. In addition to anatomical complexities, there are other factors that may complicate its management, such as polypharmacy, frailty, and procedure-related risks. All of<a href="https://solaci.org/en/2023/10/18/complex-coronary-angioplasty-in-elderly-patients-problem-or-solution/" title="Read more" >...</a>

EuroPCR 2023 | Left Main Coronary Artery Angioplasty: One or Two Stents?

The EBC MAIN LM study randomized 467&nbsp;patients with severe left main coronary artery (LCA) lesions to receive provisional stenting or a two-sent strategy (Resolute or Onix stent). The two-stent strategy was decided by the operator (culotte, DK-minicrush, T/TAP). The crossover rate from those randomized to provisional stenting was 22%. After a 3-year follow-up, the composite<a href="https://solaci.org/en/2023/05/21/europcr-2023-left-main-coronary-artery-angioplasty-one-or-two-stents/" title="Read more" >...</a>

Las angioplastias exitosas en pacientes mayores con oclusiones crónicas totales disminuyen la mortalidad

Coronary Angioplasty in Chronic Total Occlusions (CTO): Are There Sex Differences?

Studies and registries assessing sex differences in chronic total occlusions (CTO) are limited and women are under-represented, accounting for only 14%-21% of included patients. Even though success rate is comparable between sexes, several studies have shown higher complications rate among women.&nbsp;&nbsp; The aim of this study was to identify sex related baseline and procedural differences,<a href="https://solaci.org/en/2023/05/16/coronary-angioplasty-in-chronic-total-occlusions-cto-are-there-sex-differences/" title="Read more" >...</a>

Impacto negativo de la hipertensión pulmonar en el TAVI

Have Complications Related to Balloon Pulmonary Angioplasty Changed Since its Inception?

Balloon pulmonary angioplasty: Evolution over time and its complications Balloon pulmonary angioplasty (BPA) has grown from its beginnings as an indication for patients with chronic thromboembolic pulmonary hypertension (CTEPH) to being currently a class 1 indication for inoperable patients and/or residual CTEPH. Current evidence on this topic is underpowered, as most reports are based on<a href="https://solaci.org/en/2023/04/11/have-complications-related-to-balloon-pulmonary-angioplasty-changed-since-its-inception/" title="Read more" >...</a>

TCT 2022

TCT 2022 | Angioplasty vs. Surgery: The BEST Study Long-Term Results

The BEST study was a prospective, randomized study to compare percutaneous coronary intervention (PCI) with everolimus-eluting stents vs. myocardial revascularization surgery (MRS) in patients with multivessel disease. The analysis was interrupted early due to slow patient inclusion. The study included 880&nbsp;patients, who were randomized 438 to the PCI arm and 442 to the MRS arm.<a href="https://solaci.org/en/2022/09/26/tct-2022-angioplasty-vs-surgery-the-best-study-long-term-results/" title="Read more" >...</a>

The Best of the SOLACI-SOCIME 2022 Main Arena: New Paradigms in Angioplasty

“New Paradigms in Angioplasty,” by Dr. Gregg Stone While most studies on angioplasty in stable coronary artery disease have shown an improvement in angina frequency and exercise capacity, there is no significant reduction in death and acute myocardial infarction (AMI). Currently, one of the main factors is the definition of vulnerable plaque, because it is<a href="https://solaci.org/en/2022/08/10/the-best-of-the-solaci-socime-2022-main-arena-new-paradigms-in-angioplasty/" title="Read more" >...</a>

Top